EMILY FARMER: Open Payments
NPI 1356094742 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,136 in 101 payments from 14 companies in 2025. Trend: 2023 $1,240 · 2024 $1,862 · 2025 $2,136
Food & beverage: $2,136
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $509 |
| ABBVIE INC. | 22 | $412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $231 |
| Madrigal Pharmaceuticals | 6 | $164 |
| PFIZER INC. | 6 | $149 |
| Ipsen Biopharmaceuticals, Inc | 5 | $134 |
| Gilead Sciences, Inc. | 5 | $132 |
| GENZYME CORPORATION | 3 | $92 |
| Ardelyx, Inc. | 5 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $66 |
Products named: TREMFYA, LINZESS, REZDIFFRA, ENTYVIO, IQIRVO, MAVYRET, VELSIPITY, RINVOQ.
Industry payments across VA — which companies pay providers there.
